| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
INTEGRATIVE |
agonism induces a change in fuel metabolism and activation of an atrophy programme, but does not impair mitochondrial function in rat skeletal muscle1 Centre for Integrated Systems Biology and Medicine, Queens Medical Centre, University of Nottingham Medical School, Nottingham NG7 2UH, UK
PPAR
agonism impairs mitochondrial function, but the effect of PPAR
agonism on mitochondrial function is equivocal. Furthermore, PPAR and agonism increases muscle fatty acid oxidation, potentially via activation of FOXO1 signalling and PDK4 transcription. Since FOXO1 activation has also been suggested to increase transcription of MAFbx and MuRF-1, and thereby the activation of ubiquitin–proteasome mediated muscle proteolysis, this raises the possibility that muscle fuel selection and the induction of a muscle atrophy programme could be regulated by a single common signalling pathway. We therefore investigated the effect of PPAR (delta) agonist, GW610742, administration on muscle mitochondrial function, fuel regulation, and atrophy and growth related signalling pathways in vivo. Twenty-four male Wistar rats received vehicle or GW610742 (5 and 100 mg per kg body mass (bm)) orally for 6 days. Soleus muscle was used to determine maximal rates of ATP production (MRATP) in isolated mitochondria, gene and protein expression, and enzyme activities. MRATP were unchanged by GW610742. Muscle PDK2 and PDK4 mRNA expression increased with GW610742 (100 mg (kg bm)–1) compared to vehicle (P < 0.05), and was paralleled by a twofold increase in PDK4 protein expression (P < 0.05). The activity of 
-hydroxyacyl-CoA dehydrogenase increased with GW610742 (P < 0.05). Muscle MuRF1 and MAFbx mRNA expression was increased by GW610742 (100 mg (kg bm)–1) compared to vehicle (P < 0.05), and was matched by increased protein expression (P < 0.001), whilst Akt1 protein declined (P < 0.05). There was no effect of GW610742 on 20S proteasome activity and mRNA expression, or the muscle DNA: protein ratio. GW610742 switched muscle fuel metabolism towards decreased carbohydrate use and enhanced lipid utilization, but did not induce mitochondrial dysfunction. Furthermore, GW610742 initiated a muscle atrophy programme, possibly via changes in the Akt1/FOXO/MAFbx and MuRF1 signalling pathway.
(Received 27 April 2007;
accepted after revision 30 May 2007;
first published online 31 May 2007)
Corresponding author D. Constantin: Centre for Integrated Systems Biology and Medicine, Queens Medical Centre, University of Nottingham Medical School, Nottingham NG7 2UH, UK. Email: despina.constantin{at}nottingham.ac.uk
This article has been cited by other articles:
|
|
 |
|
  D. Constantin-Teodosiu, D. J. Baker, D. Constantin, and P. L. Greenhaff PPAR{delta} agonism inhibits skeletal muscle PDC activity, mitochondrial ATP production and force generation during prolonged contraction J. Physiol., January 1, 2009; 587(1): 231 - 239. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Mallinson, D. Constantin-Teodosiu, J. Sidaway, F. R. Westwood, and P. L. Greenhaff Blunted Akt/FOXO signalling and activation of genes controlling atrophy and fuel use in statin myopathy J. Physiol., January 1, 2009; 587(1): 219 - 230. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Crossland, D. Constantin-Teodosiu, S. M. Gardiner, D. Constantin, and P. L. Greenhaff A potential role for Akt/FOXO signalling in both protein loss and the impairment of muscle carbohydrate oxidation during sepsis in rodent skeletal muscle J. Physiol., November 15, 2008; 586(22): 5589 - 5600. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. L. Greenhaff, L. G. Karagounis, N. Peirce, E. J. Simpson, M. Hazell, R. Layfield, H. Wackerhage, K. Smith, P. Atherton, A. Selby, et al. Disassociation between the effects of amino acids and insulin on signaling, ubiquitin ligases, and protein turnover in human muscle Am J Physiol Endocrinol Metab, September 1, 2008; 295(3): E595 - E604. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Gaudel, C. Schwartz, C. Giordano, N. A. Abumrad, and P. A. Grimaldi Pharmacological activation of PPAR{beta} promotes rapid and calcineurin-dependent fiber remodeling and angiogenesis in mouse skeletal muscle Am J Physiol Endocrinol Metab, August 1, 2008; 295(2): E297 - E304. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Mazzatti, M. A. Smith, R. C. Oita, F.-L. Lim, A. J. White, and M. B. Reid Muscle unloading-induced metabolic remodeling is associated with acute alterations in PPAR{delta} and UCP-3 expression Physiol Genomics, July 1, 2008; 34(2): 149 - 161. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Nahle, M. Hsieh, T. Pietka, C. T. Coburn, P. A. Grimaldi, M. Q. Zhang, D. Das, and N. A. Abumrad CD36-dependent Regulation of Muscle FoxO1 and PDK4 in the PPAR{delta}/{beta}-mediated Adaptation to Metabolic Stress J. Biol. Chem., May 23, 2008; 283(21): 14317 - 14326. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. de Boer, A. Selby, P. Atherton, K. Smith, O. R. Seynnes, C. N. Maganaris, N. Maffulli, T. Movin, M. V. Narici, and M. J. Rennie The temporal responses of protein synthesis, gene expression and cell signalling in human quadriceps muscle and patellar tendon to disuse J. Physiol., November 15, 2007; 585(1): 241 - 251. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. M. Jucker, D. Yang, W. M. Casey, A. R. Olzinski, C. Williams, S. C. Lenhard, J. J. Legos, C. T. Hawk, S. K. Sarkar, and S. J. Newsholme Selective PPAR{delta} agonist treatment increases skeletal muscle lipid metabolism without altering mitochondrial energy coupling: an in vivo magnetic resonance spectroscopy study Am J Physiol Endocrinol Metab, November 1, 2007; 293(5): E1256 - E1264. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
